4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003130
Options or other derivatives
- Chief Patient Supply Officer acquired 1,329,528 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/tm212800-2_4seq1.xml…